197 results on '"Jonak, Constanze"'
Search Results
2. Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells
3. Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα
4. Single-cell sequencing delineates T-cell clonality and pathogenesis of the parapsoriasis disease group
5. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
6. Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis
7. Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG)
8. Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study
9. Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis
10. Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.
11. Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides
12. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma
13. Mortalität, prognostische Parameter und Behandlungsstrategien bei Mycosis fungoides.
14. Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika‐Therapie bei Patienten des Österreichischen Psoriasis‐Registers von 2004 bis 2022
15. Cutaneous T cell lymphoma atlas reveals malignant Th2 cells supported by a B cell-rich microenvironment
16. Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004–2022
17. Lymphomatoid papulosis in paediatric population: results of a multicentre retrospective cohort study
18. Single-cell RNA sequencing characterization of primary cutaneous B-cell lymphomas with their systemic counterparts
19. Health-related quality of life assessed over time in the PROCLIPI study
20. Single-cell RNA sequencing reveals crosstalk between T cells and endothelial cells in intravascular T-cell lymphoma
21. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
22. Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα
23. ISID0303 - Single-cell RNA sequencing of erythrodermic CTCL compared to atopic dermatitis and unspecific chronic erythroderma defines disease-specific markers
24. No impact of disease duration on response to tildrakizumab treatment among patients with moderate‐to‐severe plaque psoriasis: Post hoc analyses from two phase 3 (reSURFACE 1 and reSURFACE 2) and one phase 4 (TRIBUTE) studies.
25. Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria – results the APPRECIATE study
26. P-177 - Lymphomatoid papulosis in paediatric population: results of a multicentre retrospective cohort study
27. O-141 - Health-related quality of life assessed over time in the PROCLIPI study
28. O-130 - Single-cell RNA sequencing reveals crosstalk between T cells and endothelial cells in intravascular T-cell lymphoma
29. O-123 - Single-cell RNA sequencing characterization of primary cutaneous B-cell lymphomas with their systemic counterparts
30. sj-docx-1-taj-10.1177_20406223231152785 – Supplemental material for Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria – results the APPRECIATE study
31. sj-docx-2-taj-10.1177_20406223231152785 – Supplemental material for Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria – results the APPRECIATE study
32. A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs
33. Proteome Analysis Identified the PPARγ Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction
34. Single-cell RNA sequencing analyses of primary cutaneous B-cell disorders reveal distinct molecular patterns consistent with clinical behavior
35. Single‐cell RNA sequencing analysis of a COVID‐19–associated maculopapular rash in a patient with psoriasis treated with ustekinumab.
36. ESDR433 - Single-cell characterization of primary cutaneous B-cell lymphomas reveals distinct clonal properties of marginal zone, follicle center and leg-type lymphomas
37. ESDR437 - Single-cell RNA sequencing reveals specific T cell and fibroblast populations that can distinguish early mycosis fungoides from parapsoriasis and atopic dermatitis lesions
38. ESDR369 - Single-cell RNA sequencing analysis of a COVID-19-associated maculopapular rash in a psoriasis patient treated with ustekinumab
39. Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management
40. Faculty Opinions recommendation of The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee.
41. Chlormethin‐Gel zur Behandlung der Mycosis fungoides: Ein Expertenkonsens aus Deutschland, Österreich und der Schweiz (DACH‐Region) zum Therapiemanagement
42. The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region)
43. Blood will tell: profiling Sézary syndrome
44. An update on health-related quality of life from the PROCLIPI study
45. Development of EORTC/CLTF questionnaire to assess HRQOL in primary cutaneous T-cell and B-cell lymphomas: phase I
46. Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb–IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)
47. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma
48. Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells
49. Mycosis fungoides and Sézary syndrome
50. Mycosis fungoides und Sézary‐Syndrom
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.